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Polynitroxyl albumin and albumin therapy after
pediatric asphyxial cardiac arrest: effects on
cerebral blood flow and neurologic outcome
Mioara D Manole1, Patrick M Kochanek2, Lesley M Foley3, T Kevin Hitchens3,
Hülya Bayır4, Henry Alexander5, Robert Garman6, Li Ma7, Carleton JC Hsia8, Chien Ho3
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Postresuscitation cerebral blood flow (CBF) disturbances and generation of reactive oxygen species
likely contribute to impaired neurologic outcome after pediatric cardiac arrest (CA). Hence, we
determined the effects of the antioxidant colloid polynitroxyl albumin (PNA) versus albumin or
normal saline (NS) on CBF and neurologic outcome after asphyxial CA in immature rats. We induced
asphyxia for 9 minutes in male and female postnatal day 16 to 18 rats randomized to receive PNA,
albumin, or NS at resuscitation from CA or sham surgery. Regional CBF was measured serially from
5 to 150 minutes after resuscitation by arterial spin-labeled magnetic resonance imaging. We
assessed motor function (beam balance and inclined plane), spatial memory retention (water maze),
and hippocampal neuronal survival. Polynitroxyl albumin reduced early hyperemia seen 5 minutes
after CA. In contrast, albumin markedly increased and prolonged hyperemia. In the delayed period
after resuscitation (90 to 150 minutes), CBF was comparable among groups. Both PNA- and albumintreated rats performed better in the water maze versus NS after CA. This benefit was observed only
in males. Hippocampal neuron survival was similar between injury groups. Treatment of immature
rats with PNA or albumin resulted in divergent acute changes in CBF, but both improved spatial
memory retention in males after asphyxial CA.
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569; doi:10.1038/jcbfm.2011.165; published online
30 November 2011
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Introduction
Pediatric cardiac arrest (CA) results from asphyxia in
80% of cases. There are no therapies for improving
neurologic outcome in children after asphyxial
CA, with the possible exception of hypothermia,
although it remains unproven. Outcome from pedia-
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tric asphyxial CA is poor: of children who sustain
out-of-hospital CA, 30% have return of spontaneous
circulation (ROSC), 12% survive to hospital discharge, and only 4% have favorable neurologic
outcome (Donoghue et al, 2005).
Reperfusion and reoxygenation, indispensable to
restore viability during cardiopulmonary resuscitation
and after CA, may also have undesirable consequences.
Although it is indisputable that reperfusion is essential
for neuronal survival, the ideal reperfusion pattern
after CA remains undefined. After 9 minutes of
asphyxial CA in immature rats, hyperemia is seen
from 5 to 15 minutes after ROSC in subcortical structures, whereas cortical hypoperfusion appears early
and is sustained for up to 3 hours (Manole et al, 2009).
It is postulated that cerebral hyperemia is beneficial,
and hypoperfusion is detrimental for neuronal survival
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after CA (Snyder et al, 1975); however, a recent study
in experimental cerebral ischemia–reperfusion has
suggested that early postresuscitation hyperemia may
be deleterious (Pignataro et al, 2008).
Reactive oxygen and nitrogen species generated
during CA and reperfusion influence postresuscitation cerebral blood flow (CBF). Reactive oxygen and
nitrogen species produce vascular damage and loss
of autoregulation after brain injury (Nelson et al,
1992). Superoxide production increases with reperfusion after global ischemia in the brain (Kofler et al,
2005). Superoxide itself has limited reactivity; however, it reacts with nitric oxide to form peroxynitrite
in a diffusion-limited reaction, leading to decreased
nitric oxide availability, which can alter CBF after
CA (Bayir, 2005). Treatment with a superoxide
dismutase (SOD) mimetic early after CA has been
shown to improve neurologic outcome (Cerchiari
et al, 1987).
Polynitroxyl albumin (PNA) is an intravascular
antioxidant that is synthesized by covalent addition
of high molar ratio nitroxide (55:1 on average) to
albumin. Polynitroxyl albumin has been shown to
exert SOD-mimetic properties and to reduce infarct
size after focal ischemia in rats (Beaulieu et al, 1998;
Kuppusamy et al, 1996; Sugawara et al, 2001). In our
pediatric asphyxial CA model, PNA decreased
oxidative and nitrative stress induced by resuscitation with 100% oxygen (Walson et al, 2011).
Albumin, the parent compound of PNA, has also
been shown to improve perfusion and functional
outcome in models of focal cerebral ischemia
(Belayev et al, 1997, 1998, 2002; Liu et al, 2001).
Besides colloidal properties, albumin binds redoxactive transition metals, fatty acids, and heme
and has some antioxidant properties due to a free
cysteine residue (Gutteridge et al, 1984; Rowley et al,
1984). Given their large size, PNA and albumin are
generally restricted to the intravascular space if
the blood–brain barrier is intact, which is the case
early after injury in our CA model (Manole et al,
2009). Accordingly, we hypothesized that PNA will
ameliorate ischemia-induced CBF dysfunction and
improve neurologic outcome versus treatment with
albumin or normal saline (NS) after pediatric
asphyxial CA in immature rats.

Materials and methods
All experiments were approved by the Institutional Animal
Care and Use Committee at the University of Pittsburgh
and were performed in accordance with these guidelines
and regulations. We used postnatal day 16 to 18 Sprague–
Dawley rats of both sexes for CBF analysis (n = 37, 6 to 7 per
group) and for neurologic outcome (n = 42, 10 to 12 per
group). Rats were randomized to asphyxial CA (9-minute
asphyxia) or sham, and further randomized to receive one
of the following solutions at resuscitation or after sham
surgery: PNA (20 mL/kg, 10%, SynZyme Technologies,
Irvine, CA, USA), albumin (20 mL/kg, 10%, SynZyme

Technologies), or NS (20 mL/kg). Ten percent of human
serum albumin was prepared by dilution of 25% human
albumin (Baxter, Deerfield, IL, USA; USP) with NS, and was
supplied by SynZyme Technologies.

Anesthesia and Surgery
We used our established protocol (Manole et al, 2009) in
accordance with institutional guidelines. Rats underwent
tracheal intubation and central venous and arterial catheterization. Intravenous analgesia and neuromuscular
blockade were achieved using fentanyl (50 mg/kg per h)
and vecuronium (5 mg/kg per h). Ventilatory parameters
were adjusted to a target PaCO2 of 35 to 45 mm Hg. Nine
minutes of asphyxia was produced by disconnecting the
ventilator. Rats were resuscitated by reconnecting the
ventilator with FiO2 = 1.0, administration of epinephrine
(0.005 mg/kg) and sodium bicarbonate (1 mEquiv./kg), and
manual chest compressions until ROSC. At resuscitation,
we administered PNA, albumin, or NS. After ROSC,
anesthesia and neuromuscular blockade were restarted.
A FiO2 of 1.0 was maintained until 15 minutes after ROSC,
and decreased to 0.5 for the reminder of the experiment.
Shams underwent all procedures except asphyxia or
resuscitation.

Cerebral Blood Flow Measurement
Arterial spin-labeled magnetic resonance imaging perfusion maps were obtained at baseline and at 5, 10, 15, 30, 60,
90, 120, and 150 minutes after ROSC from CA or sham
surgery. Arterial spin-labeled magnetic resonance imaging
measurements were performed on a 7-T, 21-cm-bore Bruker
Biospec system (Bruker Biospec, Billerica, MA, USA) as
described previously (Manole et al, 2009). In brief, pixelby-pixel perfusion maps were generated by (MC ML)/MC,
where MC and ML are pixel intensities from the control
and labeling image, respectively. Cerebral blood flow
was determined by CBF = l  (T1obs  2a) 1  (MC ML)  MC 1
where l is the blood–brain partition coefficient of water,
assuming a spatially constant value of 0.9 mL/g. The spinlabeling efficiency a, and apparent brain tissue T1, T1obs,
were measured at baseline for all rats.

Assessment of Neurologic Outcome
Gross vestibulomotor function was assessed on days 1 to 5
after asphyxia or sham. We assessed the ability of rats to
balance on a suspended, narrow wooden beam for
60 seconds (beam balance test). We measured the maximum angle (45 to 851) at which the rat maintained its
position on an inclined plane for 10 seconds (inclined
plane test) (Fink et al, 2005). We tested spatial memory
acquisition and retention using the Morris water maze on
days 7 to 14 after asphyxia or sham surgery. Rats were
acclimated in the maze on days 7 to 9 after injury using a
visible escape platform. We then used the hidden platform
test on days 10 to 13 to assess spatial memory acquisition
using external visual cues to find the submerged escape
platform. We used probe trials on day 14 to assess spatial
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569
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memory retention with the escape platform removed and
the time spent in the target quadrant recorded (maximum
60 seconds).

A guard volume of 1 mm was used to avoid artifacts at the
tissue surface, e.g., lost caps. Neurons intersecting the
unbiased counting frame without touching the ‘forbidden
lines’ were counted. Sampling was continued to a
coefficient of error < 0.10 (coefficient of error < 10%).

Histologic Assessment: Unbiased Stereology
At 35 days after asphyxia or sham injury, rats were
anesthetized with 3% isoflurane and perfused with
250 mL ice-cold heparinized saline and 250 mL 2%
paraformaldehyde. The brains were removed, postfixed in
2% paraformaldehyde for 1 hour, placed in 30% sucrose,
and frozen with liquid nitrogen. Coronal sections were cut
at 35 mm using a cryotome, and 10 to 12 systematic random
sections were obtained throughout the dorsal hippocampus. Sections were stained with Cresyl violet. A subset of
sections was immunostained using anti-NeuN antibody to
label neurons. The two-stage combination of optical
disector and Cavalieri volume-point counting methods
was used to quantify the total number of neurons in the
CA1 and CA3 subregions of the dorsal hippocampus, as
detailed previously (Sterio, 1984); for review of stereology
procedures used in this study, see Mouton (2011). To
generate an unbiased sample of 10 to 11 sections per
animal, every fifth section was sampled in a systematicrandom manner from the total number of sections containing the dorsal hippocampus (range 50 to 70 total sections).
With assistance from a computerized stereology system
(Stereologer, Stereology Resource Center, Chester, MD,
USA), the reference space was outlined at low power
(  4), and neurons with a neuronal phenotype, including
clear nuclear membrane and nucleolus, were counted at
high magnification (  60). According to the disector
principle, thin focal-plane optical scanning was carried
out using a virtual three-dimensional disector of height
11 mm through the mean section thickness of 13.5 mm.

Statistical Analysis
Data were analyzed using SPSS version 15 (SPSS, Chicago,
IL, USA), and expressed as mean±s.e.m. We used repeatedmeasures ANOVA (analysis of variance) with Fisher’s LSD
post hoc test for physiologic parameters, CBF, motor
function tests, and visible and hidden platforms, and oneway ANOVA with Fisher’s Least Significant Difference
(LSD) post hoc test for neuronal counts and probe trial.
Hemispheric CBF, functional outcome parameters, and
neuronal counts were similar for NS- and PNA- or
albumin-treated shams; thus, we combined data for sham
groups for analysis. P < 0.05 was considered significant.

Results
Physiologic Data

The duration of CA was similar in the CA
groups. Table 1 presents physiologic data (mean
arterial pressure (MAP), PaCO2, arterial pH, and
PaO2). Both NS- and albumin-treated groups had
increased MAP versus shams at 10 minutes after
resuscitation. Shams, NS-, and PNA-treated rats had
MAP comparable with baseline, whereas albumintreated rats had increased MAP versus baseline at
10 minutes after resuscitation. pH was lower in
shams 120 minutes after resuscitation. This may

Table 1 MAP, PaO2, PaCO2, and pH at baseline and after asphyxial CA
Baseline

5 minutes

10 minutes

30 minutes

120 minutes

150 minutes

71±7
77±5
82±4
75±4

77±8
90±4*
93±6*
72±4

56±5
70±4
75±4
71±4

67±13
67±11
72±14
73±15

69±6
70±4
75±4
73±4

39±3
36±3
36±3
41±3

41±3
32±2
36±6
42±2

MAP

CA-PNA
CA-albumin
CA-NS
Sham

69±4
69±4
80±3
72±4

PCO2

CA-PNA
CA-albumin
CA-NS
Sham

33±2
35±2
38±3
36±1

43±6
51±5
44±6
39±2

pH

CA-PNA
CA-albumin
CA-NS
Sham

7.23±0.02
7.24±0.03
7.31±0.04
7.24±0.02

7.20±0.05
7.15±0.04
7.26±0.07
7.26±0.02

7.33±0.03*
7.37±0.02*
7.40±0.03*
7.21±0.02w

7.31±0.03*
7.37±0.03*
7.38±0.04*
7.20±0.02w

PaO2

CA-PNA
CA-albumin
CA-NS
Sham

203±11
175±19
216±9
212±11

176±20
178±29
217±27
198±12

266±18*
258±17*
249±17*
189±10w

275±40*
256±14
269±25
182±12

CA, cardiac arrest; NS, normal saline; PNA, polynitroxyl albumin.
*P < 0.05 versus sham, wP < 0.05 versus CA-NS.
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Cerebral Blood Flow

We report postresuscitation CBF for each rat normalized to its respective baseline (percentage baseline of
CBF, Figure 1). Postresuscitation CBF displayed
marked regional and temporal differences in the
three treatment groups.

Sham

9 min Asphyxial
Arrest

9 min Asphyxial
Arrest + Albumin

9 min Asphyxial
Arrest + PNA

Baseline
Post Resuscitation

5 min

150 min

0

500

mL/100g/min

563

Hemispheric Cerebral Blood Flow

Baseline hemispheric CBF was 183±7 mL/100g per
min. Normal saline-treated rats had increased hemispheric CBF versus shams at 5 minutes after resuscitation (54%, P < 0.001). Cerebral blood flow returned
to values comparable to shams after 10 minutes,
except for 60 minutes when hemispheric CBF was
lower than shams (34%, P < 0.05). Polynitroxyl
albumin-treated rats had hemispheric CBF similar
to shams at all time points. Albumin-treated rats
had prolonged increase in hemispheric CBF
versus shams from 5 to 15 minutes (74%, P < 0.001).
250
Hemipsheric CBF (% baseline)

result from the CA groups receiving sodium bicarbonate at resuscitation. PaO2 was statistically lower in
shams versus CA; however, this difference does not
seem physiologically meaningful.

200

*#

150

CA-PNA
CA-Albumin
CA-NS
Sham

*

*
#

* *

100
50
0
5

250

200
150

*

*

†

#

#

†

100
50

Thalamus CBF (% baseline)

Cortical CBF (% baseline)

250

0
10
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30 60 90
Time (min)

30 60 90 120 150
Time (min)

*#
*#
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*
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*
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*

100
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120 150

5

250
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30 60 90
Time (min)

120 150

250
Amygdalic CBF (% basel ine)

Hippocampus CBF (% baseline)

15

0
5

200

10

*#
*

150
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50
0

200

*#
#†

150

*#† *#† *#† *#† *#†

100
50
0

5

10

15

30 60 90
Time (min)

120 150

5

10

15

30 60 90
Time (min)

120 150

Figure 1 Regional postresuscitation CBF, percentage change from baseline. Color flow map of CBF at baseline, 5 and 150 minutes
after CA. (*P < 0.05 CA-albumin versus shams; #P < 0.05 CA-NS versus shams; wP < 0.05 CA-PNA versus shams). CA, cardiac
arrest; CBF, cerebral blood flow; NS, normal saline; PNA, polynitroxyl albumin.
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Hemispheric CBF decreased to values comparable to
shams at 30 minutes, and below shams from 120 to
150 minutes (26%, P < 0.001).
Hemispheric CBF differed between the CA groups.
Albumin-treated rats had increased hemispheric CBF
versus NS-treated rats from 10 to 60 minutes
(P < 0.05). Polynitroxyl albumin-treated rats had
similar CBF with NS-treated rats with the exception
of decreased CBF at 5 minutes (P < 0.05).
Cortical Cerebral Blood Flow

Baseline cortical CBF was 178±6 mL/100 g per min.
Cortical CBF of NS-treated rats was comparable to
shams in the first 30 minutes after resuscitation and
lower than shams 60 to 90 minutes (38%, P < 0.05).
Polynitroxyl albumin-treated rats had cortical CBF
similar to shams, except for 10 and 150 minutes
when CBF was lower than shams (42%, P < 0.05).
Albumin-treated rats had increased cortical CBF
versus shams at 5 and 30 minutes (34%, P < 0.05),
reduced cortical CBF versus shams at 120 minutes
(33%, P < 0.05).
Cortical CBF was different between the CA groups.
Albumin-treated rats had increased cortical CBF
versus NS-treated rats from 15 to 60 minutes
after resuscitation (P < 0.05). Polynitroxyl albumintreated rats had similar CBF as NS-treated rats with
the exception of decreased CBF at 5 minutes
(P < 0.05).
Thalamic Cerebral Blood Flow

Baseline thalamic CBF was 228±11 mL/100 g per
min. In NS-treated rats, thalamic CBF was increased
versus shams at 5 to 10 minutes (88%, P < 0.001) and
similar to shams from 15 to 150 minutes. In PNAtreated rats, thalamic CBF was similar to shams at all
time points. In albumin-treated rats, thalamic CBF
was markedly increased versus shams from 5 to
60 minutes (120% at 5 minutes, P < 0.05). Cerebral
blood flow decreased to values comparable to shams
at 90 minutes and was lower than shams at 150 minutes (21%, P < 0.05).
Thalamic CBF was different between CA groups.
Albumin-treated rats had increased thalamic CBF
versus NS-treated rats at 30 to 60 minutes after
resuscitation (P < 0.05). Cerebral blood flow in
PNA-treated rats was similar to NS-treated rats with
the exception of decreased CBF at 5 minutes
(P < 0.05).
Hippocampal Cerebral Blood Flow

Baseline hippocampal CBF was 211±10 mL/100 g
per min. Normal saline-treated rats had increased
hippocampal CBF versus shams at 5 minutes (70%,
P < 0.001), with no difference afterwards. Cerebral
blood flow in PNA-treated rats was similar to shams
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569

at all time points. Albumin-treated rats had hippocampal CBF increased versus shams at 5 to 10 minutes (83%, P < 0.001) and similar to shams after
15 minutes.
Hippocampal CBF was similar in the CA groups,
except for decreased CBF at 5 minutes in PNAversus NS-treated rats (P < 0.05).
Amygdalic Cerebral Blood Flow

Baseline amygdalic CBF was 134±6 mL/100 g per
min. Normal saline-treated rats had increased amygdalic CBF versus shams (75%, P < 0.001) at 5 minutes, followed by decreased CBF versus shams from
15 to 60 minutes (46% at 15 minutes, P < 0.05).
Polynitroxyl albumin-treated rats had CBF similar
to shams until 10 minutes and lower than shams
from 15 to 60 minutes (50% at 15 minutes, P < 0.05).
Albumin-treated rats had increased CBF at 5 minutes
versus shams (86%, P < 0.001), and then decreased
CBF versus shams from 30 minutes (35%, P < 0.05).
Amygdalic CBF was similar in the CA groups,
except for decreased CBF at 5 minutes in PNAversus NS-treated rats (P < 0.05).
Postresuscitation Cerebral Blood Flow in Male and
Female Rats

There were no hemispheric sex-dependent CBF
differences in our study (n = 3 to 4 per sex per group,
data not shown). There were no regional sex-dependent CBF differences except for two time points. At 5
and 10 minutes, albumin-treated female rats had
higher thalamic CBF than did NS-treated females.
Functional Outcome

Beam Balance and Inclined Plane Test: There were
no differences between treatments after CA in either
beam balance or inclined plane performance (Figures
2A and 2B). All CA groups had decreased beam
balance performance versus shams from days 1 to 4
(P < 0.05, Figure 2A). On the final day of beam
balance testing, albumin and NS-treated rats performed similar to shams, whereas PNA-treated rats
performed worse than shams (P < 0.05). On the
inclined plane, the CA groups performed worse than
shams on the first 2 days of testing (P < 0.05). There
were no differences between groups on days 3 to 5
(Figure 2B). There were no sex-dependent differences in beam balance or inclined plane test
performance between treatment groups (n = 5 to 6
per sex per group).
Morris Water Maze: Visible Platform. On the first and
third days of acclimatization in the water maze, there
was no difference in performance between groups.
On the second day, PNA-treated rats had reduced
latency to finding the platform versus NS-treated rats
(P < 0.05). All groups except for albumin-treated rats
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Figure 2 (A) Beam balance, (B) inclined plane test, (C) hidden platform test (*P < 0.05 CA-albumin versus shams, #P < 0.05 CANS versus shams, wP < 0.05 CA-PNA versus shams). (D) Probe trial. Triangles represent individual rats in each group, males (m) or
females (D), (*P < 0.05 versus CA-NS). CA, cardiac arrest; NS, normal saline; PNA, polynitroxyl albumin.

improved the ability to find the platform from the
first to the third day of acclimatization (P < 0.05 for
shams, PNA- and NS-treated rats; P = 0.3 for albumin-treated rats). There was an overall effect of time
(P < 0.001). The overall performance of the four
groups was similar (P = 0.2). There were no sexdependent differences between groups, except for
the first day of acclimatization: NS-treated female
rats performed better than both PNA- and albumintreated female rats (n = 5 to 6 per sex per group).
Hidden Platform. There was an overall effect of
time (P < 0.001). On the first day of testing, PNAtreated rats had reduced latency to finding the
hidden platform versus NS-treated rats (P < 0.05),
performing similar to shams (Figure 2C). During the
subsequent days, all groups except for PNA-treated
rats improved the ability to find the hidden platform
from the first to the fourth day, showing the ability to
learn the task (P < 0.05 for shams, albumin- and NS-

treated rats; P = 0.1 for PNA-treated rats). There was
no difference among groups on the final day of the
hidden platform test. The overall performance of the
four groups was similar (P = 0.3). There were no sexdependent differences between groups (n = 5 to 6 per
sex per group).
Probe Trial. After hidden platform testing, we
measured the time spent in the quadrant where the
platform was previously located. Random swimming
in all four quadrants would yield a time in the target
quadrant of 15 seconds of the total 60-second testing
period. Albumin- and PNA-treated rats spent more
time in the target quadrant versus NS-treated rats
(P < 0.05). On post hoc analysis, this difference was
attributable to benefit in males (n = 5 to 6 per sex per
group, Figure 2D). The power to detect a difference
for groups and genders in the probe trial was 0.145.
This gender difference in performance could not be
explained by different durations of CA in males and
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569

PNA and albumin after pediatric CA
MD Manole et al
566

a

b

Neuronal count in dorsal
hippocampus
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Figure 3 (a) Neuronal counts in the CA1 hippocampus. Triangles represent individual rats in each group, males (m) or females (D).
(*P < 0.05 versus shams). (b) Representative photomicrographs of the CA1 hippocampus stained with Neu-N from a representative
shams (A), CA-NS (B), CA-PNA (C), and CA-albumin (D) rat. Size bar = 60 mm. CA, cardiac arrest; NS, normal saline; PNA,
polynitroxyl albumin.

females. The durations of CA in minutes were
5.5±0.4 versus 6.2±0.3 for PNA, 5.6±0.5 versus
5.6±0.5 for albumin, and 5.5±0.6 versus 4.7±0.6
for NS in male and female rats, respectively.

Neuropathological Outcome

The CA groups had decreased CA1 hippocampal
neuronal survival versus shams (P < 0.05). There were
no differences in cell counts among CA treatment
groups and no difference between males and females
(n = 5 to 6 per sex per group). Hippocampal neuronal
counts in dorsal CA1 were 46,160±2,933 for shams,
and 18,989±3,951, 22,053±2,853, and 21,848±
2,803 for the CA groups treated with PNA, albumin,
and NS, respectively (P < 0.05 CA groups versus
shams) (Figure 3). There were no differences in CA3
hippocampal neuronal survival between CA groups
and shams. Hippocampal neuronal counts in dorsal
CA3 were 25,635±1,869 for shams, and 26,929±
3,479, 24,822±3,078, and 25,635±1,869 for CA
groups treated with PNA, albumin, and NS, respectively (P = 0.8, 0.6, and 0.3 versus shams).

Discussion
To our knowledge, this is the first study exploring the
effects of the intravascular antioxidant colloid PNA
or albumin on either CBF or functional outcome after
asphyxial CA in immature animals. Polynitroxyl
albumin and albumin produced divergent CBF
changes after asphyxial CA. Polynitroxyl albumin
prevented early hyperemia, whereas albumin exacerbated hyperemia in all brain regions, including
the cortex, a region where hypoperfusion is seen.
Remarkably, despite divergent CBF changes, both
PNA and albumin improved functional outcome
assessed by the probe trial test compared with NS.
The decrease in postresuscitation CBF after PNA
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569

suggests that reactive oxygen and nitrogen species
contribute to hyperemia after CA. The improved
functional outcome after PNA and albumin despite
divergent early CBF changes suggests four possibilities: (1) either blunting or exacerbating early
hyperemia is beneficial, (2) alterations of CBF do
not influence functional outcome, (3) PNA improves
functional outcome independent of effects on CBF, or
(4) albumin improves functional outcome independent of effects on CBF in our pediatric asphyxial
CA model.
Polynitroxyl albumin is a colloid that has nitroxide
moieties with potent antioxidant properties (Kuppusamy et al, 1996). Nitroxides act as electron scavengers and have SOD-mimetic activity. Polynitroxyl
albumin has been shown to attenuate superoxideinduced vascular adhesion of leukocytes to endothelial cells versus albumin (Russell et al, 1998). The
dismutation of superoxide yields hydrogen peroxide
(Yost and Fridovich, 1976). Hydrogen peroxide is a
relatively stable molecule; however, it can produce
hydroxyl radical, which is a potent reactive oxidant,
in the presence of transition metals in their reduced
states (Rowley and Halliwell, 1983). Hydrogen
peroxide is removed primarily by glutathione peroxidases. We have shown that CA leads to depletion of
glutathione, protein nitration, and lipid peroxidation, which were prevented by PNA (Walson et al,
2011). Polynitroxyl albumin has beneficial effects
in models of focal ischemia–reperfusion (Steinbauer
et al, 2000; Zhang et al, 2000) and focal brain
ischemia (Beaulieu et al, 1998; Sugawara et al, 2001).
Albumin is a colloid that increases MAP
in hypovolemia. A beneficial effect of albumin in
neurologic pathologies is suggested by studies
in stroke and traumatic brain injury in which lower
serum albumin levels are associated with poor
outcome (Bernard et al, 2008; Idicula et al, 2009).
Albumin has beneficial effects in animal models of
focal ischemia (Belayev et al, 1997, 2002; Liu et al,
2001); however, it was not found to be neuroprotec-
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tive either in a neonatal model of stroke or after
clinical traumatic brain injury in adults (Myburgh
et al, 2007; Wang et al, 2007). Albumin’s beneficial
effects for focal ischemia–reperfusion are attributed
to antioxidant properties, inhibition of copper-induced peroxidation, fatty acid oxidation (Gutteridge
et al, 1984; Rowley et al, 1984; Yao et al, 2010),
binding of fatty acids and heme, and early upregulation of vascular endothelial growth factor (Yao et al,
2010). Albumin contains one free cysteine moiety,
which is believed to be the key scavenger of reactive
oxygen and nitrogen species generated in the
intravascular compartment (O’Neill et al, 1993).
However, it has been shown that human serum
albumin preparations commonly used in the clinic
are predominantly oxidized at the free cysteine,
which was resistant to reduction (Lang et al, 2004).
Postresuscitation CBF was divergently affected by
administration of PNA and albumin versus NS in our
model. The blood–brain barrier is intact to gadoteridol (a molecule smaller than albumin) in the first
3 hours after resuscitation in our model (Manole
et al, 2009), and consequently, we expect that PNA
and albumin exert their effects in the intravascular
space. Similar to our findings with PNA, SOD
administration reduced early postresuscitation hyperemia in an asphyxial CA model in dogs (Cerchiari
et al, 1987), and administration of SOD-albumin
complex improved blood flow and neurologic outcome in a global ischemia–reperfusion model (Takeda et al, 1993). Similar to our study, albumin was
shown to improve cortical perfusion after permanent
focal cerebral ischemia (Liu et al, 2001) and
improved perfusion in the microcirculation during
the postischemic reperfusion period (Belayev et al,
2002). One possible explanation for our findings is
mitigation of superoxide-induced vascular dysfunction by PNA versus albumin. Superoxide causes
microvascular abnormalities such as loss of autoregulation after ischemia, and treatment with scavengers of superoxide can prevent the loss of
autoregulation (Nelson et al, 1992). Intravascular
antioxidants such as PNA may mitigate the effect of
superoxide, attenuate postischemic vascular injury,
and prevent the loss of blood pressure autoregulation
of CBF after CA. By preventing the loss of autoregulation, PNA may prevent hyperemia early after
ROSC, whereas albumin, by increasing MAP and/or
cardiac output in the absence of such vascular
protection, further promotes cerebral hyperemia.
MAP increases early postresuscitation in our rats,
but would be expected to remain in the autoregulatory range (Pryds et al, 2005). This possibility is
supported by data showing that PNA, but not
albumin, inhibits the superoxide-induced adherence
of polymorphonuclear cells to the endothelium
(Russell et al, 1998). Another mechanism by which
albumin produces hyperemia may be attributed to
formation of S-nitroso-albumin. It was shown that
albumin binds nitric oxide at the free cysteine and
forms S-nitroso-albumin, a compound with endothe-

lium-derived relaxing factor-like properties, vasodilatory effects on coronary vessels, and a half-live
substantially longer than nitric oxide (Ignarro, 1989;
Keaney et al, 1993). Additional mechanistic studies
would be required to test these hypotheses.
We serially quantified CBF using baseline measurement for a and T1obs because repeated measurement of these parameters would preclude serial
measurement of perfusion maps. We recognize that
injection of nitroxides can reduce blood and tissue
T1 (Hyodo et al, 2008). To validate our approach, we
serially measured these parameters after injection of
PNA or albumin in separate rats. We noted a small
decrease in T1obs with both agents. However, both
PNA and albumin are large molecules that are
restricted to the blood pool, and we attribute this
effect to a change in the blood pool T1. We believe
that the baseline measurement provides a better
representation of the tissue T1 during the study. The
PNA used in the study has a free tempol concentration of B1 mmol/L. A global effect of T1 is seen in
rapid T1-weighted images; however, the free nitroxide is reduced quickly and does not affect serial
CBF. This was confirmed by repeating experiments
with tempol-free PNA in several rats. After albumin
administration, a decreased slightly. This can be
attributed to an additional magnetization transfer
effect in the arterial blood as a result of the larger
concentration of macromolecules. We did not correct
for this magnetization transfer effect, but the result
leads to an underestimate of CBF by B8% for the
albumin-treated group. No difference in a is seen
after the administration of PNA. The bound nitroxides efficiently relax the macromolecular nuclear
spins blunting the additional magnetization transfer
effect in the arterial blood.
Morris water maze performance was improved by
both PNA and albumin after CA in male rats.
Similarly, PNA or SOD confer neuroprotection after
global ischemia, and thus, amelioration of vascular
injury by PNA may improve outcome (Cerchiari et al,
1987; Kofler et al, 2005; Schleien et al, 1994). The
improved functional outcome after albumin administration in our study was not surprising because
albumin is also beneficial in animal models of focal
ischemia: decreased infarct area, reduced brain
edema, and improved functional outcome (Belayev
et al, 1997, 1998). Albumin improved neurologic outcome in a pilot study in humans after stroke
(Ginsberg et al, 2006) and a multicenter, randomized
controlled trial of albumin in acute ischemic stroke is
underway.
Neither PNA nor albumin attenuated CA1 hippocampal neuronal death versus NS. Thus, the degree
of hippocampal neuronal death cannot be directly
linked to the degree of early postresuscitation CBF
derangements in our model. Further studies are
required before a definitive conclusion can be drawn
regarding the influence of blunting or augmenting
early hyperemia on neuronal death. We selected the
CA1 hippocampus given its vulnerability in this
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 560–569
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model and the capacity to quantify neuronal counts
through stereology (Fink et al, 2005). Quantification
of neuronal death in other anatomic areas after CA is
warranted. Thalamic areas in particular have early
hyperemia that intensified after treatment with
albumin. Systematic characterization of thalamic
pathology in different thalamic nuclei, along with
quantification of gliosis and axonal injury in our
model are important and the object of further study
(Shoykhet et al, 2011).
Our data suggest that males treated with PNA or
albumin have improved spatial memory retention after
CA. We found no significant sex-dependent difference
in postresuscitation CBF, gross vestibulomotor function, or neuronal loss. Our findings might relate to the
evidence of a greater role for oxidative stress in males
versus females (Du et al, 2004). At the time of testing,
rats were 31-days old; thus, in addition to possible
effects of innate gender differences at the time of
injury, hormonal influences in males may contribute
to the gender effects seen on functional outcome.
However, because our study was not initially designed
for sex-dependent analysis, the power to detect a sex
difference was low and prospective evaluation of sexdependent effect is warranted. Our work does support
evaluation of sex-dependent treatment effects, even in
prepubertal neuronal injury models.
Administration of PNA or albumin at resuscitation
is mimicking the clinical scenarios of in-hospital CA
or administration at resuscitation by first responders
(emergency medical personnel) in an out-of-hospital
CA. Assessment of delayed administration of PNA or
albumin on neurologic outcome and the time
window of administration of PNA and albumin to
optimize cerebrovascular-targeted therapies is also
valuable and will be evaluated in future studies.

Summary
Despite divergent effects on hyperemia early after CA
in postnatal day 16 to 18 rats, both PNA and albumin
modestly improved neurologic outcome in our
model in a sex-dependent manner.
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